from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0819/mshD

LFCtreatmentdescriptionclass of inhibitor

0.297

Amikacinug/mL Amikacintranslation

-1.393

Cap5-10ug/mL Capreomycintranslation

-1.268

Rox10-50 ug/mL Roxithromycintranslation

-0.435

SM2-5 ug/mL Streptomycintranslation

-1.034

Tet5-10 ug/mL Tetracyclinetranslation

1.441

Rif0.2-5ug/mL Rifampicintranscription

1.265

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.453

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.317

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.034

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.074

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.575

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.112

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.637

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.565

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.662

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.275

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.095

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.014

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.001

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.448

KCN5-20 ug/mL Potassium cyaniderespiration

0.040

NaN30.2-2 mM Sodium aziderespiration

-0.985

Nigericin50 uM Nigericinrespiration

0.275

TRC10-150 ug/mL Triclosanrespiration

0.468

TRZ10-25 ug/mL Thioridazinerespiration

-0.658

Valinomycin0.5-10 uM Valinomycinrespiration

-0.871

ZnSO42 mM ZnSO4respiration

-0.042

menadione6-10 ug/mL Menadionerespiration

-0.360

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.743

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.188

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.776

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.388

NRP_1Non-replicating persistence stage 1dosRassociated

-0.241

Amp0.2mg/mL AmpicillincellWall

-0.289

Cephalexin20-100 ug/mL CephalexincellWall

-0.772

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.406

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.094

EMB10-20 ug/mL EthambutolcellWall

-0.431

Eta12-40 ug/mL EthionamidecellWall

-0.416

INH0.2-0.4 ug/mL IsoniazidcellWall

0.657

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.793

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.674

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.164

BZA0.12 mg/mL BenzamidearomaticAmides

0.667

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.353

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.074

H2O24 mM hydrogen peroxideDNAdamaging

-0.015

Levo10 ug/mL LevofloxacinDNAdamaging

-0.624

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.162

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.694

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.830

UVUV-irradiationDNAdamaging

0.934

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.518

Antimycin12.5-50 ug/mL Antimycin A?

-0.329

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.789

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.059

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.801

PA8240.2-2 ug/mL PA-824?

0.545

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.384

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.049

Verapamil50 uM Verapamil?

0.393

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.525

methoxatin10-20 ug/mL Methoxatin?